superman99
Politcal Worker (100+ posts)
I’m a physician in the US and working in oncology drug Development. Please don’t pay heed to such individuals. If he’s developed an anti-viral for SARS-COV 2, he should share pre-Clinical data that show’s its efficacy. Drug doesn’t get approved so quickly, after animal and lab testing, you start with phase 1 trial to make sure that the drug is safe. Then you do the same in a bit larger group to make sure that the drug is safe and effective. You only get a license to commercialize after phase 3 studies - in this case, FDA may give an anti-viral against SARS-COV 2 a breakthrough designation due to huge unmet need